American Journal of Cardiology
Volume 102, Issue 11 , Pages 1469-1472 , 1 December 2008

Emergency Pretreatment for Contrast Allergy Before Direct Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Received 4 June 2008 ,Accepted 22 July 2008.

References 

  1. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al 2007 Focused update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 2008;51:210–247
  2. Freed KS, Leder RA, Alexander C, DeLong DM, Kliewer MA. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. AJR. 2001;176:1389–1392
  3. Goss J, Chamber C, Heupler F. Systemic anaphylactoid reactions to iodinated contrast media during cardiac catheterization procedures: guidelines for prevention, diagnosis and treatment. Catheter Cardiovasc Intervent. 1995;34:99–104
  4. Mohan JC, Reddy KS, Bhatai ML. Anaphylactoid reaction to angiographic contrast media: Recurrence despite pretreatment with corticosteroids. Catheter Cardiovasc Intervent. 1984;10:465–469
  5. Greenberger PA, Halwig JM, Patterson R, Wallemark CB. Emergency administration of radiocontrast media in high-risk patients. J Allergy Clin Immunol. 1986;77:630–634
  6. Greenberger PA, Patterson R, Radin RC. Two pretreatment regimens for high-risk patients receiving radiographic contrast media. J Allergy Clin Immunol. 1984;74:540–543
  7. Lasser EC, Berry CC, Tainer LB, Santini LC, Lang EK, Gerber FH, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med. 1987;317:845–849
  8. Wittbrodt ET, Spinler SA. Prevention of anaphylactoid reactions in high-risk patients receiving radiographic contrast media. Ann Pharmacother. 1994;28:236–241
  9. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990;175:621–628
  10. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology. 1997;203:605–610
  11. Morcos SK. Acute serious and fatal reactions to contrast media: our current understanding. Brit J Radiol. 2005;78:686–693
  12. Wolf GL, Mishkin MM, Roux SG, Halpern EF, Gottlieb J, Zimmerman J, et al. Comparison of the rates of adverse drug reaction: ionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol. 1991;26:404–410
  13. Ring J, Rothenberger KH, Clauss W. Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1 and H2-receptor antagonists: results of a prospective controlled trial. Int Arch Allergy Appl Immunol. 1985;78:9–14
  14. Siegle RL, Halvorsen RA, Dillon H, Gavant ML, Halpern E. The use of iohexol in patients with previous reactions to ionic contrast media. Invest Radiol. 1991;26:411–416
  15. Bush WH, Swanson DP. Acute reactions to intravascular contrast media: types risk factors, recognition, and specific treatment. AJR. 1991;157:1153–1161
  16. Seymour R, Halpin SF, Hardman JA, Coote JM, Ruttley MST, Roberts GM. Corticosteroid prophylaxis for patients with increased risk of adverse reactions to intravascular contrast agents: a survey of current practice in the UK. Clin Radiol. 1994;49:791–795
  17. Radhakrishnan S, Manoharan S, Fleet M. Repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk of adverse reaction to intravascular contrast agents. Clin Radiol. 2005;60:58–63
  18. Morcos SK, Thomsen HS, Webb JAW Contrast Safety Committee of the European Society of Urogenital Radiology. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur J Radiol. 2001;11:1720–1728
  19. Webb JAW. Repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk of adverse reaction to intravascular contrast agents. Clin Radiol. 2005;60:727–730
  20. Dawson P, Sidhu PS. Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reaction to intravascular contrast agents?. Clin Radiol. 1993;38:225–226
  21. Lieberman P, Kemp SF, Oppenheimer J, Lang D, Bernstein IL, Nicklas RA, et al. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115(suppl):S483–S523
  22. American College of Radiology. Manual on Contrast Media Version 5.0: (2004) Patient Selection and Preparation Strategies. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/contrast_manual.aspxAccessed December 12, 2007
  23. Delaney A, Carter A, Fisher M. The prevention of anaphylactoid reactions to iodinated radiological contrast media: a systematic review. BMC Med Imaging. 2006;6:1–7
  24. Thomsen HS, Morcos SK Members of Contrast Media Safety Committee of the European Society of Urogenital Radiology. Management of acute adverse reactions to contrast media. Eur J Radiol. 2004;14:476–481
  25. Thomsen HS. European Society of Urogenital Radiology guidelines on the safe use of iodinated contrast material. Euro J Radiol. 2006;60:307–313
  26. Strait R, Morris SC, Smiley K, Urban JF, Finkelman FD. IL-4 exacerbates anaphylaxis. J Immunol. 2003;170:3835–3842

PII: S0002-9149(08)01265-4

doi: 10.1016/j.amjcard.2008.07.040

American Journal of Cardiology
Volume 102, Issue 11 , Pages 1469-1472 , 1 December 2008

Article Tools